The Risk of Overdiagnosis of Antiphospholipid Antibody Syndrome

Thromb Haemost 2001; 86(03): 933
DOI: 10.1055/s-0037-1616156

Letters to the Editor

Schattauer GmbH

Autoren

V. Pengo

¹Department of Clinical and Experimental Medicine, Thrombosis Center, University of Padova, Italy
A. Biasiolo

¹Department of Clinical and Experimental Medicine, Thrombosis Center, University of Padova, Italy

References
1 Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999; 42: 1309-11.
2 Pengo V, Biasiolo A, Fior MG. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when β₂-Glycoprotein-I is bound to a suitable surface. Thromb Haemost 1995; 73: 29-34.
3 Pengo V, Biasiolo A, Brocco T, Tonetto S, Ruffatti A. Autoantibodies to phospholipid binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies. Thomb Haemost 1996; 75: 721-4.
4 Rampazzo P, Biasiolo A, Garin J, Rosato A, Betterle C, Ruffatti A, Pengo V. Some patients with antiphospholipid syndrome express hitherto undescribed antibodies to cardiolipin-binding proteins. Thromb Haemost 2001; 85: 57-62.